William Aliski

Director, Ultragenyx Pharmaceutical Inc.

Companies

X4 Pharmaceuticals, IncBoard member Sep 20, 2019 to Jun 11, 2024¹
Applied Genetic Technologies CorporationBoard member Sep 24, 2018 to Dec 1, 2022²
Ultragenyx Pharmaceutical Inc.Board member Jan 30, 2014 to Jun 28, 2021³

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

X4 Pharmaceuticals, Inc XFOR96,667 shares⁴$248.0K at $2.56Jun 10, 2024
Applied Genetic Technologies Corporation AGTC0 shares⁵Nov 30, 2022

As of each latest filing. The line shows shares held over time.

Recent filings

Jun 10, 2024Granted 45,000 shares of X4 Pharmaceuticals, Inc⁴
Jun 13, 2023Granted 45,000 shares of X4 Pharmaceuticals, Inc⁶
Nov 30, 2022U 8,500 shares of Applied Genetic Technologies Corporation⁵
Jun 6, 2022Granted 6,667 shares of X4 Pharmaceuticals, Inc⁷

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARX4 Pharmaceuticals, Inc, Board member
2
SEC EDGARApplied Genetic Technologies Corporation, Board member
3
SEC EDGARUltragenyx Pharmaceutical Inc., Board member
4
SEC EDGARX4 Pharmaceuticals, Inc shares after the filing of Jun 10, 2024
5
SEC EDGARApplied Genetic Technologies Corporation shares after the filing of Nov 30, 2022
6
SEC EDGARForm 4 filed Jun 14, 2023
7
SEC EDGARForm 4 filed Jun 27, 2022